KURA files Form 144 to sell 10,000 RSUs

KURA reported a proposed sale of 10,000 shares of Common Stock via Form 144.

Rhea-AI Filing Summary

KURA reported a proposed sale of 10,000 shares of Common Stock via Form 144.

The filing lists 10,000 shares of restricted stock units to be sold with an aggregate value of $103,400.00 and a filing date of 05/21/2026. The report also discloses 10b5-1 sales of 339 shares on 05/19/2026 for $3,122.19.

Insights

Corporate Governance Specialist

Form 144 notifies the market of an intended insider sale of restricted stock units.

The filing lists 10,000 restricted stock units proposed for sale and records prior 10b5-1 trades of 339 shares on 05/19/2026. This is a regulatory notice of proposed disposition, not a transaction completion statement.

Timing and exact distribution methods beyond the 10b5-1 sale are not detailed in the excerpt; subsequent filings or broker reports would show execution details.

Key Figures

Proposed sale: 10,000 shares Aggregate value listed: $103,400.00 Prior 10b5-1 sale: 339 shares +2 more

5 metrics

Proposed sale 10,000 shares restricted stock units, filing dated 05/21/2026

Aggregate value listed $103,400.00 associated with the 10,000 shares, 05/21/2026

Prior 10b5-1 sale 339 shares sold on 05/19/2026 under a 10b5-1 plan

Proceeds from prior sale $3,122.19 proceeds reported for the 339-share 10b5-1 sale on 05/19/2026

Filing date 05/21/2026 Form 144 filing date shown in the excerpt

Key Terms

Restricted Stock Units, 10b5-1, Form 144

3 terms

Restricted Stock Units financial

"Securities To Be Sold ... Restricted Stock Units ... 10000"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for BRIAN POWL ... 05/19/2026 ... 339"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information ... 144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did KURA disclose in the Form 144?

The Form 144 reports a proposed sale of 10,000 shares of Common Stock as restricted stock units, with an aggregate value listed as $103,400.00. It also records a 10b5-1 sale of 339 shares on 05/19/2026 for $3,122.19.

Who executed recent sales related to the filing?

The excerpt shows 10b5-1 sales attributed to Brian Powl, reporting 339 shares sold on 05/19/2026. The Form 144 itself lists the proposed issuer sale of 10,000 restricted stock units with a 05/21/2026 filing date.

Does the Form 144 confirm the 10,000 shares have been sold?

No. The Form 144 lists a proposed sale of 10,000 restricted stock units and provides an aggregate value; it is a notice of intent and does not by itself confirm completion of the sale or timing of execution.

What is the role of a 10b5-1 mention in this filing?

The filing records prior trades executed under a prearranged plan: a 10b5-1 sale of 339 shares on 05/19/2026. Such disclosures show previously executed sales under a plan but do not specify future sale mechanics for the 10,000-unit proposal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 04:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001934232
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KURA ONCOLOGY INC
SEC File Number	001-37620
Address of Issuer	4930 Directors Place, Suite 500 San Diego CALIFORNIA 92121
Phone	8585008800
Name of Person for Whose Account the Securities are To Be Sold	BRIAN POWL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	103400.00	88774365	05/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2025	Restricted Stock Units	Issuer			10000	11/13/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRIAN POWL 4930 Directors Place, Suite 500 San Diego CA 92121	Common	05/19/2026	339	3122.19

144: Remarks and Signature

Remarks
Date of Notice	05/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brian Powl
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)